ABSTRACT The four serotypes of dengue virus (DENV) cause one of the most important and rapidly emerging mosquito-borne viral diseases in humans. Of the currently available diagnostic tests for dengue, the reverse transcription-PCR (RT-PCR) assay is the most sensitive and specific, and so it is commonly used as the gold standard. However, the requirement of a sophisticated and expensive thermal cycler makes it very difficult to use as a point-of-care diagnostic test in resourcelimited regions where dengue is endemic. Tsai et al. (J Clin Microbiol 56:e01865-17, 2018, https://doi.org/10.1128/JCM.01865-17) report the analytical and clinical performances of a reverse transcription-insulated isothermal PCR (RT-iiPCR) assay with a portable nucleic acid analyzer for rapid detection of the four DENV serotypes; its reproducibility and complete agreement on clinical samples with the multiplex RT-PCR assay developed by the Centers for Disease Control and Prevention suggest that the dengue RT-iiPCR is a potential point-of-care test. Compared with other DENV RNA detection methods, the unique isothermal PCR design of RT-iiPCR, together with further improvements, would represent a promising new type of field-deployable diagnostic test for dengue.
high specificity of the assay using pan-DENV primers and probe was demonstrated by the lack of detection of 14 non-DENV human viruses; the reproducibility was supported by consistent results from repeat testing by six operators at three sites. Compared with the Centers for Disease Control and Prevention (CDC) reference test, the RT-iiPCR assay showed comparable detection endpoints with four DENV serotypes (8, 9) . In testing performed with 256 clinical samples, the RT-iiPCR assay showed complete agreement (100%; 95% confidence interval [CI 95% ], ϳ98.81% to 100%; ϭ 1) with the CDC quantitative RT-PCR assay.
In the field of molecular diagnosis, several isothermal amplification modalities such as loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), thermophilic helicase-dependent amplification (tHDA), and recombinase polymerase amplification (RPA) have been developed for the detection of different DNA or RNA microorganisms, including those causing malaria (10, 11) . For molecular diagnosis of dengue, reverse transcription-LAMP (RT-LAMP) has been reported previously as a potential field-deployable POC test (12) (13) (14) (15) (16) . Results of comparisons of the RT-PCR, RT-iiPCR, and RT-LAMP tests for dengue regarding the principles, equipment, primers/probes, reagent stability, time, and detection capability with respect to different DENV serotypes or related viruses are summarized in Table 1 .
The iiPCR system is unique in its employment of a thermally baffled device and a single heating source to drive Rayleigh-Bernard convection to allow the three steps of PCR (denaturation, annealing, and extension) to occur in different temperature zones (22, 23) . Since the first report of the assay in 2012, the RT-iiPCR or iiPCR system (via the use of a Pockit nucleic acid analyzer) has been widely applied for rapid detection of various parasitic, bacterial, and viral pathogens in animals and humans, including Plasmodium, Salmonella, bluetongue virus, foot-and-mouth disease virus, classical swine fever virus, influenza A virus, and coronavirus (24) (25) (26) (27) . A previous study of RT-iiPCR for dengue samples reported sensitivity of 90.5% and specificity of 98.3% compared with a composite 3-assay reference, including the CDC quantitative RT-PCR (qRT-PCR) assay (17) . The study by Tsai et al. further validated the RT-iiPCR test for dengue diagnosis with higher sensitivity and specificity (8) . The rapid, simple, convenient, and user-friendly protocol of the Pockit nucleic acid analyzer, together with its small size, portable design, rechargeable battery, and the option of an automatic RNA extraction system, makes it a promising POC diagnostic modality for dengue. The RT-iiPCR assay for dengue has successfully completed two independent clinical evaluations (8, 17) and has shown very encouraging results. Since both studies were carried out in research laboratories, however, studies in different regions or countries of dengue endemicity are needed to further validate its performance as a POC test. There are several limitations of the RT-iiPCR test. First, it cannot distinguish different DENV serotypes. Given that multiple DENV serotypes have been cocirculating in regions of endemicity and that two or more DENV serotypes were reported increasingly during the same outbreak, several RT-PCR or RT-LAMP tests have been developed in multiplex format to detect and distinguish different DENV serotypes (9, (12) (13) (14) . Future development of multiplex RT-iiPCR for dengue would greatly improve its clinical applications to better understand the extent and serotypes of infecting virus in the field sites. Second, the dengue RT-iiPCR test can test only 8 samples at the maximum; future design enhancements to increase its detection capacity would make it more useful during outbreak investigations. Additionally, it cannot detect other arboviral infections with similar clinical presentations such as Zika virus (ZIKV) and chikungunya virus (CHIKV). The recent spread of CHIKV followed by ZIKV to regions of the Americas where DENV is endemic highlights the importance of distinguishing these three arboviruses in regions of dengue endemicity. Several triplex RT-PCR or RT-LAMP tests have been developed to detect DENV, ZIKV, and CHIKV simultaneously (15, 16, (18) (19) (20) (21) . Future development of the RT-iiPCR test into a multiplex format to cover ZIKV and CHIKV would significantly strengthen the utility of this potential POC test in the field.
